← Browse by Condition
Medical Condition

colorectal carcinoma

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4, Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for colorectal carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — colorectal carcinoma Clinical Trials

How many clinical trials are currently recruiting for colorectal carcinoma?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for colorectal carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for colorectal carcinoma?
colorectal carcinoma research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a colorectal carcinoma clinical trial?
Eligibility criteria for colorectal carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
1
Phase 4
1
Top Sponsors
Oslo University Hospital 1 trial
RenJi Hospital 1 trial
Memorial Sloan Kettering Cancer Center 1 trial
Meri Mirceta 1 trial
Asklepios Kliniken Hamburg GmbH 1 trial

Recruiting Clinical Trials

NCT02073500
Recruiting
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Enrollment
300 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT06685497
Recruiting
COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
Enrollment
236 pts
Location
China
Sponsor
RenJi Hospital
View Trial →
NCT04812912
Recruiting
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
Enrollment
120 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06935708 Phase 4
Recruiting
Intrathecal Morphine Versus Epidural Analgesia for Open Colon Surgery
Enrollment
98 pts
Location
Croatia
Sponsor
Meri Mirceta
View Trial →
NCT07099924
Recruiting
Rectus Sheath Catheters Following Midline Laparotomy
Enrollment
40 pts
Location
Germany
Sponsor
Asklepios Kliniken Hamburg Gmb...
View Trial →
NCT06130826 Phase 1
Recruiting
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Enrollment
24 pts
Location
United States
Sponsor
City of Hope Medical Center
View Trial →
NCT06926374
Recruiting
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Enrollment
90 pts
Location
China
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT05786924 Phase 1, Phase 2
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Enrollment
554 pts
Location
United States, Austr...
Sponsor
Institut de Recherches Interna...
View Trial →
NCT06376565
Recruiting
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Enrollment
1,680 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C...
View Trial →

Related Conditions

colorectal cancer (2) pseudomyxoma peritonei (1) ovarian carcinoma (1) mesothelioma (1) colorectal neoplasms (1) analgesia postoperative (1) laparotomy (1) acute abdomen (1) ileus (1) breast carcinoma (1) rectal prolapse (1) prostate cancer adenocarcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology